SPOTLIGHT -
EP. 1: When to Suspect Sarcoma
EP. 2: Soft Tissue Sarcoma: Factors Impacting Initial Approach
EP. 3: Challenges in Treating Soft Tissue Sarcomas in Younger Populations
EP. 4: Goals of Therapy in Sarcoma
EP. 5: Local Control in Metastatic Soft Tissue Sarcoma
EP. 6: Chemotherapy Sensitivity in Soft Tissue Sarcoma
EP. 7: Frontline Approach in Advanced Sarcomas
EP. 8: Sequencing Decisions in Soft Tissue Sarcoma
EP. 9: Recent Approvals in Soft Tissue Sarcoma
EP. 10: The Role of Trabectedin in Sarcoma Subtypes
EP. 11: Efficacy and Toxicities with Trabectedin in Sarcomas
EP. 12: Eribulin Mesylate in Soft Tissue Sarcoma
EP. 13: Olaratumab Efficacy in Soft-Tissue Sarcoma
EP. 14: Soft Tissue Sarcoma: Looking Ahead
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
